IZIFUNDO ZAMANJE

I-FUCASO iyinguquko yokwelapha eqondiswe ku-BCMA eqondiswe ku-CAR-T eyenziwe yi-IASO BIO, enikeza ukusebenza kahle okungenakuqhathaniswa nokuphepha kwe-myeloma eminingi ebuyele emuva noma ephikisayo. Ngamazinga aphezulu okuphendula, ukuxolelwa okuhlala isikhathi eside, kanye nephrofayili yokuphepha eqinile, i-FUCASO inikeza ithemba elisha ezigulini futhi ibeka izinga elisha ekwelapheni kwe-CAR-T.

I-CAR-T Therapy, emfushane ye-Chimeric Antigen Receptor T-Cell Immunotherapy, iyindlela yokwelapha ethuthukisiwe yofuzo ehlanganisa ukuguqula ufuzo amaseli T esiguli ukuze aqondise futhi abhubhise amangqamuzana omdlavuza. Ngokungafani nemithi yendabuko, ukwelashwa kwe-CAR-T kwenzelwe isiguli ngasinye futhi kudinga ukuqoqa ama-T cell egazini lesiguli ngaphambi kokuba abuyiselwe emzimbeni ngemva kobunjiniyela bofuzo.